Stock chart
Analyses on Millennium Fdtc (4)
- March 19, 2026March 19, 2026
- Follow-up
Paper Value Versus Accessible Value: Millennium’s Liquidity, Warrants, and Dilution Stack
Even after the early-2026 rights offering, Millennium’s accessible value remains much smaller than its paper value. Series 2 can add cash, but as long as the unit trades below the strike, it represents a dilution layer first and a liquidity layer only conditionally.
- Follow-up
How Firm Is Millennium’s Book Value: Tipa and TripleW Under the Hood
Tipa and TripleW explain why Millennium still carries meaningful asset value on its balance sheet, but at year-end 2025 that value rests more on models, management-supplied inputs and rolled-forward marks than on a fresh external pricing anchor, which makes it softer than the ba…
- Follow-up
Pitolon After FDA: Is 2026 a Commercialization Year or Just Another Funding Round?
The FDA approval moves Pitolon from pure regulatory possibility into a first real commercialization attempt, but the disclosed cash balance, burn rate, and explicit need for additional funding still make 2026 look more like a funded launch year than a self-financing commercializ…
Millennium Food-Tech in 2025: The Book Value Is Still There, but Getting to It Still Runs Through Funding
Millennium's book value is still meaningful, but it is concentrated in three private holdings that still depend on commercialization and funding, so the stock's deep discount mainly reflects doubt about access to value rather than only doubt about whether the value exists.
